期刊文献+

Team players in the pathogenesis of metabolic dysfunctionsassociated steatotic liver disease:The basis of development of pharmacotherapy

下载PDF
导出
摘要 Nutrient metabolism is regulated by several factors.Social determinants of health with or without genetics are the primary regulator of metabolism,and an unhealthy lifestyle affects all modulators and mediators,leading to the adaptation and finally to the exhaustion of cellular functions.Hepatic steatosis is defined by presence of fat in more than 5%of hepatocytes.In hepatocytes,fat is stored as triglycerides in lipid droplet.Hepatic steatosis results from a combination of multiple intracellular processes.In a healthy individual nutrient metabolism is regulated at several steps.It ranges from the selection of nutrients in a grocery store to the last step of consumption of ATP as an energy or as a building block of a cell as structural component.Several hormones,peptides,and genes have been described that participate in nutrient metabolism.Several enzymes participate in each nutrient metabolism as described above from ingestion to generation of ATP.As of now several publications have revealed very intricate regulation of nutrient metabolism,where most of the regulatory factors are tied to each other bidirectionally,making it difficult to comprehend chronological sequence of events.Insulin hormone is the primary regulator of all nutrients’metabolism both in prandial and fasting states.Insulin exerts its effects directly and indirectly on enzymes involved in the three main cellular function processes;metabolic,inflammation and repair,and cell growth and regeneration.Final regulators that control the enzymatic functions through stimulation or suppression of a cell are nuclear receptors in especially farnesoid X receptor and peroxisome proliferator-activated receptor/RXR ligands,adiponectin,leptin,and adiponutrin.Insulin hormone has direct effect on these final modulators.Whereas blood glucose level,serum lipids,incretin hormones,bile acids in conjunction with microbiota are intermediary modulators which are controlled by lifestyle.The purpose of this review is to overview the key players in the pathogenesis of metabolic dysfunction-associated steatotic liver disease(MASLD)that help us understand the disease natural course,risk stratification,role of lifestyle and pharmacotherapy in each individual patient with MASLD to achieve personalized care and target the practice of precision medicine.PubMed and Google Scholar databases were used to identify publication related to metabolism of carbohydrate and fat in states of health and disease states;MASLD,cardiovascular disease and cancer.More than 1000 publications including original research and review papers were reviewed.
作者 Shahid Habib
出处 《World Journal of Gastrointestinal Pathophysiology》 2024年第4期1-29,共29页 世界胃肠病理生理学杂志(英文版)(电子版)
  • 相关文献

参考文献4

二级参考文献139

  • 1Qing-Qing Zhang,Lun-Gen Lu.Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy[J].Journal of Clinical and Translational Hepatology,2015,3(1):78-84. 被引量:23
  • 2Dong Yun Kim,Jun Yong Park.Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?[J].Hepatobiliary Surgery and Nutrition,2019,8(5):522-524. 被引量:2
  • 3Christos D Zois,Gerasimos H Baltayiannis,Anna Bekiari,Anna Goussia,Peter Karayiannis,Michalis Doukas,Demetrios Demopoulos,Antigoni Mitsellou,Theodoros Vougiouklakis,Vasiliki Mitsi,Epameinondas V Tsianos.Steatosis and steatohepatitis in postmortem material from Northwestern Greece[J].World Journal of Gastroenterology,2010,16(31):3944-3949. 被引量:6
  • 4Paola Dongiovanni,Benedetta Donati,Roberta Fares,Rosa Lombardi,Rosellina Margherita Mancina,Stefano Romeo,Luca Valenti.PNPLA3 I148M polymorphism and progressive liver disease[J].World Journal of Gastroenterology,2013,19(41):6969-6978. 被引量:19
  • 5Zhiqiang Zhao,Junjie Hou,Zhensheng Xie,Jianwei Deng,Xiaoming Wang,Danfang Chen,Fuquan Yang,Weimin Gong.Acyl-biotinyl Exchange Chemistry and Mass Spectrometry-Based Analysis of Palmitoylation Sites of In Vitro Palmitoylated Rat Brain Tubulin[J]. The Protein Journal . 2010 (8)
  • 6Hensel J,Hintz M,Karas M,Linder D,Stahl B,Geyer R.Localiza- tion of the palmitoylation site in the transmembrane protein p12E of Friend murine leukemia virus. European Journal of Biochemistry . 1995
  • 7Hoffman MD,Kast J.Mass spectrometric characterization of lipid-modified peptides for the analysis of acylated proteins. Journal of Mass Spectrometry . 2006
  • 8Yang W,Di Vizio D,Kirchner M,Steen H,Freeman MR.Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Molecular and Cellular Proteomics . 2010
  • 9Merrick BA,Dhungana S,Williams JG,Aloor JJ,Peddada S,Tomer KB,Fessler MB.Proteomic profiling of S-acylated macrophage proteins identifies a role for palmitoylation in mitochondrial target- ing of phospholipid scramblase. .
  • 10Noritake J,Fukata Y,Iwanaga T,Hosomi N,Tsutsumi R,Matsuda N,Tani H,Iwanari H,Mochizuki Y,Kodama T,Matsuura Y,Bredt DS,Hamakubo T,Fukata M.Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. The Journal of Cell Biology . 2009

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部